In the pathology laboratories, we analyze cell and tissue samples and conduct hospital autopsies. The pathologist examines samples under a microscope and gives a statement on the sample, which is then sent to the referring physician.
Our division includes the pathology laboratories in Meilahti, Hyvinkää, Jorvi, Kymenlaakso, and South Karelia. The organ transplantation and hematology laboratory operates in connection with the Meilahti pathology laboratory.
We conduct approximately 430,000 tests every year. An important part of our work is case meetings, which are organized in cooperation with almost all the clinical specialties. We work in close cooperation with clinicians from different fields.
Helsinki Urological Cancer Research Group centers around the clinical and academic work done at the HUS Helsinki University Hospital and Helsinki University. Department of urology is the largest in Finland with an catchment area of ca. 1.5M inhabitants and 25 staff members. Our center is a tertiary referral center for centralized surgery (e.g. Cystectomy, prostatectomy, urethraplasty, RPLND) but at the same time also responsible for the primary diagnostics, treatments and follow-up of all urological cancers in greater Helsinki area.
Prostate cancer research group, co-led by assistant professor Antti Rannikko (clinical site) and associate professor Tuomas Mirtti (pathology and preclinical site) is the core of the Helsinki Prostate Cancer Research Center (PCRC).
Kidney cancer research group is an active and growing group of researchers led by associate professor Harry Nisen (urology). The group has several retrospective and prospective studies and trials ongoing and on the pipeline. It actively collaborates with local, national and international experts in clinical, translational and preclinical collaborative projects.
Bladder cancer group is co-led by urologist, PhD, Jukka Sairanen (invasive bladder cancer) and urologist, PhD, Riikka Järvinen (superficial bladder cancer).
The group has several retrospective and prospective studies and trials ongoing and on the pipeline. It actively collaborates with local, national and international experts in clinical, translational and preclinical collaborative projects.
Penile cancer research group is led by urologist, PhD, Hanna Vasarainen.